Vector Biocontainment Laboratory
To facilitate research on infectious diseases that are classified as a major public health threat such as SARS CoV-2, Lyme disease, Powassan encephalitis, West Nile encephalitis, Zika virus disease, Chikungunya virus disease, Dengue fever and Malaria at different biocontainment levels (BSL-2, ABSL-2, BSL-3, and ABSL-3).
Key Functions VBL
The VBL will provide an avenue for researchers to collaborate on cutting-edge research on emerging infectious diseases with the overall objective of developing novel countermeasures to control and prevent infections.
For additional information to utilize VBL for your research and grant application, contact
Saravanan Thangamani, PhD
Director, Vector Bio-containment Laboratories (VBL)